Irina Grimberg
Internal Medicine · Anchorage, AKNPI 1144313198
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.9% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 37.6% of the total. Reporting peaked in 2019 at $1,110 and has fallen 78.9% since, to $234 in 2025. Among internal medicine clinicians in AK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 92 payments — averaging $31.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$328
- Novo Nordisk$189
- Pfizer$168
- GSK$167
- Amgen$159
- plus $777 from 12 others
What the payments were for
- Food & beverage$2,68994%
- Education$1746%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 30 | $1,075 |
| AstraZeneca | 6 | $328 |
| Novo Nordisk | 8 | $189 |
| Pfizer | 22 | $168 |
| GSK | 4 | $167 |
| Amgen | 2 | $159 |
| Lilly USA, LLC | 7 | $125 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $122 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $100 |
| Astellas Pharma US Inc | 1 | $99 |
| Regeneron Healthcare Solutions, Inc. | 1 | $85 |
| Regeneron | 1 | $71 |
| Johnson & Johnson | 1 | $55 |
| Novartis | 3 | $55 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Aurinia Pharma U.S., Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,863 in reported general payments places this provider in the 90th percentile of 124 internal medicine providers in Alaska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xeljanz XrTofacitinib Citrate | 16 | $159,710 |
| Taltz AutoinjectorIxekizumab | 13 | $88,462 |
| Humira(Cf) PenAdalimumab | 12 | $81,738 |
| OzempicSemaglutide | 22 | $38,864 |
| EliquisApixaban | 15 | $23,441 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 16 | $17,434 |
| Omega-3 Acid Ethyl Esters | 78 | $5,705 |
| Nebivolol Hcl | 35 | $3,126 |
| Hydroxychloroquine Sulfate | 36 | $2,768 |
| SynthroidLevothyroxine Sodium | 17 | $2,260 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $1,127 |
| Amlodipine-ValsartanAmlodipine Besylate/Valsartan | 14 | $1,117 |
| Raloxifene Hcl | 17 | $722 |
| Irbesartan | 14 | $583 |
| Rosuvastatin Calcium | 37 | $483 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $189 | $38,86422 claims |
| PfizerEliquis | $168 | $23,44115 claims |
| AbbVieSynthroid | $1,075 | $2,26017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 124 internal medicine providers in Alaska.
Other internal medicine in Anchorage
- Loretta LeeAnchorage$8K
- Susan HeverlingAnchorage$6K
- Laurie MontanoAnchorage$6K
- Michele O FallonAnchorage$6K
- Alvaro RosalesAnchorage$4K
- Robin MillerAnchorage$4K
- Mary DemersAnchorage$3K
- Thuy-Trang NgoAnchorage$3K
- Brian TrimbleAnchorage$1K
- Julie McCormickAnchorage$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.